Mirae Asset Global Investments Co., Ltd. Sutro Biopharma, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,263 shares of STRO stock, worth $2,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,263
Previous 2,676
21.94%
Holding current value
$2,610
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding STRO
# of Institutions
118Shares Held
60.5MCall Options Held
95.8KPut Options Held
38.5K-
Suvretta Capital Management, LLC New York, NY7.46MShares$5.97 Million0.21% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$5.53 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.44MShares$4.35 Million0.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.43MShares$3.55 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.4MShares$3.52 Million0.0% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $41.7M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...